…decline in older birth cohorts, for nine of the remaining cancers including breast cancer (estrogen-receptor positive only), uterine corpus cancer, colorectal cancer, non-cardia gastric cancer, gallbladder cancer, ovarian cancer, testicular…
Search Results: Liver Cancer (221)
…liver (steatosis), liver inflammation (steatohepatitis and alcoholic hepatitis), scarring (fibrosis and cirrhosis), and even liver cancer (hepatocellular carcinoma or HCC). Chronic alcohol use speeds up liver damage, and factors such…
…associated with obesity and type 2 diabetes and can progress to cirrhosis, liver failure, or even liver cancer. Published in The Lancet, the study reports that the drug, known as…
…Medicine, indicate that a drug that mimics a hormone in the body improved both liver fibrosis, or scarring of the liver, and liver inflammation in patients with NASH. Rohit Loomba,…
…it can lead to cirrhosis, liver failure, and even liver cancer. Millions of people are affected by nonalcoholic steatohepatitis (NASH), which is a serious liver disease. A newly discovered amino…
…along with nutrients from food to activate immune cells that trigger inflammation. In this way, elements of the gut microbiome may drive liver disease, including fatty liver disease and liver…
…cancer, according to research entitled “Restoration of a youthful gut microbiome reduces liver aging and suppresses tumorigenesis in older mice” presented at Digestive Disease Week (DDW) 2026. Liver cancer is…
A nationwide study in Sweden indicates that GLP1 agonists, such as Ozempic, could lower the risk of cirrhosis and liver cancer in individuals with type 2 diabetes and chronic liver…
…condition did not co-occur with liver metastases, suggesting that causing fatty liver and preparing the liver for metastasis are distinct strategies that cancers use to manipulate liver function,” said co-first…
Scientists have found two types of MASLD—one targeting the liver and another impacting various organs—which could enhance diagnosis and treatment approaches for this widespread disease. Two types of fatty liver…
…Cellular Biophysics at The Rockefeller University FLC is a rare liver cancer with unique genetic traits, often misdiagnosed until advanced. New research and a clinical trial offer hope for effective…
…red, which serve as biomarkers in liver cancer. Credit: Krainer Lab, CSHL Because liver cancer is particularly diverse, genetically, and prone to relapse, identifying biomarkers that can predict disease progression…
…human liver cancer, hepatocellular carcinoma. On the right is a tumor subtype associated with a rarer liver cancer, mostly found in children, named hepatoblastoma. Credit: Beyaz lab/Cold Spring Harbor Laboratory…
…cancer, in which ARTEMIS detected individuals with liver cancer among others with cirrhosis or viral hepatitis with an AUC of 0.87. When combined with DELFI, the AUC increased to 0.90….
…by scar tissue—have an increased risk of developing liver cancer. This scarring disrupts blood flow and impairs liver function. Patients with advanced liver cancer and cirrhosis are typically not considered…
…a condition formerly known as non-alcoholic fatty liver disease. It is a multisystem disorder, with a very heterogeneous origin and a diverse course that can degenerate into cirrhosis, liver cancer,…
…diabetes (T2D). NAFLD encompasses a range of liver conditions caused by the accumulation of fat in the liver. This can result in liver fibrosis, which can advance to cirrhosis (liver…
A new chemistry breakthrough makes it possible to cheaply recreate cancer-fighting molecules found in guava. The discovery could lead to more accessible treatments for deadly liver cancers and beyond. Credit:…